Cornerstone Investments
Contributor since: 2016
Latest Articles
MedMen: CFO Left Amid Disastrous Equity Offering
Canopy Growth: A Little Hiccup Won't Derail Its Dominance
Weekly Cannabis Report: Canadian Earnings Disappoint, Acreage RTO
Tilray: That Quarter Was As Weak As It Could Get
Cronos: Another Weak Quarter Reinforces Our Cautiousness
CannTrust's Confusing CEO Appointment And Its Future
Aurora Cannabis: That Quarter Was A Step In The Right Direction
Curaleaf: A Disastrous Public Debut That Was Priced Expensive
Weekly Cannabis Report: Mexico And U.S. Moving Closer To Pot Legalization
Best Ways To Play The U.S. Cannabis Industry (Part 2)
Namaste's Last Quarter Was A Total Disaster
Terra Tech To Acquire Golden Leaf: Little To Cheer About
MedMen Lost $79 Million In The Last Quarter
Hexo: A Forgettable Quarter
Weekly Cannabis Report: U.S. Beats Canada In Major Rebound
Best Ways To Play The U.S. Cannabis Industry (Part 1)
Canopy's Secret Ambition To Dominate The Hemp Industry
PepsiCo Needs Cannabis More Than It Realized
Aurora Cannabis: What To Do During This Sell-Off?
Weekly Cannabis Report: The Sell-Off Is Here, What To Do?
Why A Deal Between Altria And Aphria Makes Sense
Khiron: This Cannabis Stock Could Be The Perfect Takeout Target
Why Did Aurora Abandon Green Organic Dutchman?
iAnthus Became A Top U.S. Cannabis Play After MPX Deal
Terra Tech's Open Letter To President Donald Trump
Weekly Cannabis Report: Sell The News Or Buy The Dips?
Aurora Shareholders Just Got A Little Richer
The Reason Why Green Thumb Lost 35% In A Month
Aphria: A Quarter Filled With Operational Challenges
Canopy Rivers: This Canopy-Affiliated Stock Is On Sale After 30% Drop
MedMen: Why The PharmaCann Acquisition Was Such A Steal
Canada's Pot Legalization Is Going To Be A Big Mess